References
- Ferreira SB, Kaiser CR. Pyrazine derivatives: a patent review (2008 – present). Expert Opin Ther Pat. 2012;22:1033–1051. doi: 10.1517/13543776.2012.714370
- Zhang YB, Wang XL, Liu W, et al. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors. Bioorg Med Chem. 2012;20:6356–6365. doi: 10.1016/j.bmc.2012.08.059
- Saha S, Venkata Ramana Reddy C, Chiranjeevi T, et al. The first total synthesis and biological evaluation of marine natural products ma’edamines A and B. Bioorg Med Chem Lett. 2013;23:1013–1016. doi: 10.1016/j.bmcl.2012.12.033
- Kuo G-H, Prouty C, Wang A, et al. Synthesis and structure–activity relationships of pyrazine-pyridine biheteroaryls as novel, potent, and selective vascular endothelial growth factor receptor-2 inhibitors. J Med Chem. 2005;48:4892–4909. doi: 10.1021/jm058205b
- Suzuki Y, Suzuki A, Tamaru A, et al. Rapid detection of pyrazinamide-resistant mycobacterium tuberculosis by a PCR-based in vitro system. J Clin Microbiol. 2002;40:501–507. doi: 10.1128/JCM.40.2.501-507.2002
- Milczarska B, Foks H, Zwolska Z. Studies on pyrazine derivatives, XLIII: synthesis and antituberculosis activity of 6-(1,2,3,4-tetrahydroisoquinolino) and 6-(1,3,3-trimethyl-6-azabicyclo-[3,2,1]-octano)-pyrazinocarboxylic acid derivatives. Phosphorus Sulfur Silicon Relat Elem. 2005;180:2255–2264. doi: 10.1080/104265090917835
- Cynamon MH, Speirs RJ, Welch JT. In vitro antimycobacterial activity of 5-chloropyrazinamide. Antimicrob Agents Chemother. 1998;42:462–463.
- Seitz LE, Suling WJ, Reynolds RC. Synthesis and antimycobacterial activity of pyrazine and quinoxaline derivatives. J Med Chem. 2002;45:5604–5606. doi: 10.1021/jm020310n
- Rajini KS, Aparna P, Sasikala C, et al. Microbial metabolism of pyrazines. Crit Rev Microbiol. 2011;37:99–112. doi: 10.3109/1040841X.2010.512267
- Le Bourdonnec B, Goodman AJ, Graczyk TM, et al. Synthesis and pharmacological evaluation of novel octahydro-1H-pyrido[1,2-a]pyrazine as μ-opioid receptor antagonists. J Med Chem. 2006;49:7290–7306. doi: 10.1021/jm0604878
- Nakamura A, Ono M, Segawa H, et al. Studies on herbicidal 2,3-pyrazinedicarbonitriles (2,3-dicyanopyrazines). Part IV. Synthesis and herbicidal activity of 6-phenyl-5-propylamino-2-pyrazinecarbonitriles and related compounds. Agric Biol Chem. 1984;48:1009–1016.
- Sato, N. Pyrazines and their benzo derivatives. In: Katritzky AR, Ramsden CA, Scriven EFV, Taylor RJK, editors. Comprehensive heterocyclic chemistry III. Vol. 8. Amsterdam: Elsevier; 2008. p. 305.
- Al-Azmi A, Elassar A-ZA, Booth BL. The chemistry of diaminomaleonitrile and its utility in heterocyclic synthesis. Tetrahedron. 2003;59:2749–2763. doi: 10.1016/S0040-4020(03)00153-4
- Ungoren SH, Dilekoglu E, Koca I. Synthesis of pyrazine-2,3-dicarbonitrile and 1,2,4-triazine-5(4H)-one derivatives from furan-2,3-diones. Chinese Chem Lett. 2013;24:1130–1133. doi: 10.1016/j.cclet.2013.08.001
- Kabirifard H, Ghahremani S, Afsharpoor A. A simple and versatile protocol for the preparation of functionalized heterocycles utilizing 4-benzoyl-5-phenylamino-2,3-dihydrothiophene-2,3-dione. J Sulfur Chem. 2015;36:591–605. doi: 10.1080/17415993.2015.1074687
- Schick H, Eichhorn I. Syntheses and reactions of 2-alkyl-1,3-cyclopentanediones (2-alkyl-3-hydroxy-2-cyclopenten-1-ones). Synthesis. 1989;1989(7):477–492. doi: 10.1055/s-1989-27297